(Q40817534)

English

Prognostic factors for overall survival in elderly patients with advanced ovarian cancer treated with chemotherapy: Results of a pooled analysis of three GINECO phase II trials

scientific article published on April 2016

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Prognostic factors for overall survival in elderly patients with advanced ovarian cancer treated with chemotherapy: Results of a pooled analysis of three GINECO phase II trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

Eric Pujade-Lauraine

5

object named as

Eric Pujade-Lauraine

0 references

2

object named as

Gilles Freyer

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

author name string

Fabien Tinquaut

1

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Franck Chauvin

3

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Nicolas Gane

4

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Claire Falandry

6

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

language of work or name

0 references

publication date

1 April 2016

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

143

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

22-26

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.018

7 January 2021

Epithelial ovarian carcinoma in younger vs older women: is age an independent prognostic factor? The Hellenic Oncology Cooperative Group experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.018

7 January 2021

Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.018

7 January 2021

Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.018

7 January 2021

Comprehensive geriatric assessment for older patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.018

7 January 2021

Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.018

7 January 2021

Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the eld

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.018

7 January 2021

Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.018

7 January 2021

Carboplatin/cyclophosphamide or carboplatin/paclitaxel in elderly patients with advanced ovarian cancer? Analysis of two consecutive trials from the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.018

7 January 2021

Lymphocyte subpopulations in depressed elderly women

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.018

7 January 2021

Peripheral white blood cells and HPA axis neurohormones in major depression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.018

7 January 2021

Abnormal glucose tolerance, white blood cell count, and telomere length in newly diagnosed, antidepressant-naïve patients with depression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.018

7 January 2021

Depression and cancer mortality: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.018

7 January 2021

Impact of improved nutritional status on survival in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.018

7 January 2021

Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged >or=70 years with advanced ovarian cancer--a study by the AGO OVAR Germany

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.018

7 January 2021

A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.03.018

7 January 2021

Identifiers

10.1016/J.YGYNO.2016.03.018

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40817534&oldid=1970624004"